Presence or absence of anticardiolipin antibodies (aCLs), lupus anticoagulant (LAC), and IgG class anti-β2GPI antibodies in patients of the study population
. | . | aCLs . | . | LAC . | . | IgG anti-β2GPI . | . | |||
|---|---|---|---|---|---|---|---|---|---|---|
| Disorder . | Total, n . | Present, n . | Absent, n . | Present, n . | Absent, n . | Present, n . | Absent, n . | |||
| SLE | 176 | 93 | 83 | 46 | 130 | 36 | 140 | |||
| LLD | 16 | 13 | 3 | 12 | 4 | 11 | 5 | |||
| PAPS | 6 | 6 | 0 | 5 | 1 | 5 | 1 | |||
| Total | 198 | 112 | 86 | 63 | 135 | 52 | 146 | |||
. | . | aCLs . | . | LAC . | . | IgG anti-β2GPI . | . | |||
|---|---|---|---|---|---|---|---|---|---|---|
| Disorder . | Total, n . | Present, n . | Absent, n . | Present, n . | Absent, n . | Present, n . | Absent, n . | |||
| SLE | 176 | 93 | 83 | 46 | 130 | 36 | 140 | |||
| LLD | 16 | 13 | 3 | 12 | 4 | 11 | 5 | |||
| PAPS | 6 | 6 | 0 | 5 | 1 | 5 | 1 | |||
| Total | 198 | 112 | 86 | 63 | 135 | 52 | 146 | |||
SLE indicates systemic lupus erythematosus; LLD, lupuslike disease; and PAPS, primary antiphospholipid syndrome.